Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT164 | Organism | Human herpesvirus 4 | Human herpesvirus 4 | Inhibition | = | 19.7 | % | 17877337 |
NPT164 | Organism | Human herpesvirus 4 | Human herpesvirus 4 | Inhibition | = | 100 | % | 19877653 |
NPT2 | Others | Unspecified | Potency | 6740 | nM | 16038541 | ||
NPT2 | Others | Unspecified | Potency | 7497.8 | nM | 15711537 | ||
NPT26 | Individual Protein | Reverse transcriptase | Human immunodeficiency virus 1 | IC50 | = | 2.2 | ug/ml | 22197393 |
NPT80 | Cell Line | Raji | Homo sapiens | Activity | = | 70 | % | 16562843 |
NPT2 | Others | Unspecified | Potency | 6007 | nM | 19285414 | ||
NPT2 | Others | Unspecified | Potency | 29849.3 | nM | 20813528 | ||
NPT2 | Others | Unspecified | Potency | 23710.1 | nM | 10.6019/CHEMBL1201861 | ||
NPT164 | Organism | Human herpesvirus 4 | Human herpesvirus 4 | IC50 | = | 15.9 | nM | 23631483 |
NPT2 | Others | Unspecified | Potency | 3790.2 | nM | 17567069 | ||
NPT2 | Others | Unspecified | Potency | 2683.2 | nM | 8158155 | ||
NPT74 | Individual Protein | Proto-oncogene c-JUN | Homo sapiens | Potency | 26832.5 | nM | 19371071 | |
NPT2 | Others | Unspecified | AC50 | 44668.4 | nM | 12880316 | ||
NPT163 | Individual Protein | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens | Potency | 10682.2 | nM | 15332848 | |
NPT2 | Others | Unspecified | Inhibition | = | 82 | % | 21082802 | |
NPT2 | Others | Unspecified | Inhibition | = | 64 | % | 21082802 | |
NPT2 | Others | Unspecified | Inhibition | = | 57 | % | 21082802 | |
NPT2 | Others | Unspecified | Inhibition | = | 59 | % | 9584401 | |
NPT162 | Individual Protein | Heat shock protein beta-1 | Homo sapiens | Potency | 11882.3 | nM | 13678412 | |
NPT2 | Others | Unspecified | Potency | 237.1 | nM | 12662101 | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 3349.1 | nM | 23046382 | |
NPT2 | Others | Unspecified | Potency | 1508.9 | nM | 18183025 | ||
NPT164 | Organism | Human herpesvirus 4 | Human herpesvirus 4 | Inhibition | = | 56 | % | 10.6019/CHEMBL1201861 |
NPT2 | Others | Unspecified | Inhibition | = | 56 | % | 23977995 | |
NPT2 | Others | Unspecified | Inhibition | = | 29 | % | 23977995 | |
NPT2 | Others | Unspecified | Inhibition | = | 90 | % | 23977995 | |
NPT2 | Others | Unspecified | Inhibition | = | 28 | % | 23977995 | |
NPT2 | Others | Unspecified | Inhibition | = | 40 | % | 23977995 | |
NPT2 | Others | Unspecified | Inhibition | = | 13 | % | 23977995 | |
NPT2 | Others | Unspecified | Inhibition | = | -40 | % | 23977995 | |
NPT2 | Others | Unspecified | Inhibition | = | 28.25 | % | 24328283 | |
NPT2 | Others | Unspecified | Inhibition | = | 41.59 | % | 24328283 | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 2391.4 | nM | 10869203 | |
NPT2 | Others | Unspecified | Potency | 29849.3 | nM | 15217289 | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 1693 | nM | 22445674 | |
NPT2 | Others | Unspecified | Activity | = | 1.5 | 15497961 | ||
NPT2 | Others | Unspecified | Potency | 25118.9 | nM | 20392109 | ||
NPT2 | Others | Unspecified | Potency | 4216.3 | nM | 18183025 | ||
NPT2 | Others | Unspecified | Potency | 5353.8 | nM | 27109867 | ||
NPT2 | Others | Unspecified | Potency | 7497.8 | nM | 22085418 | ||
NPT2 | Others | Unspecified | Potency | 1508.9 | nM | 24387703 | ||
NPT2739 | Individual Protein | Tyrosinase | Mus musculus | Inhibition | = | 26 | % | 21377877 |
NPT2739 | Individual Protein | Tyrosinase | Mus musculus | Inhibition | = | 29 | % | 21377877 |
NPT2 | Others | Unspecified | Inhibition | = | 28 | % | 10924160 | |
NPT2 | Others | Unspecified | Inhibition | = | 13 | % | 10924160 | |
NPT164 | Organism | Human herpesvirus 4 | Human herpesvirus 4 | Inhibition | = | 84.7 | % | 18667320 |
NPT2 | Others | Unspecified | Inhibition | = | 51 | % | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Inhibition | = | 69 | % | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Inhibition | = | 92 | % | 23944963 | |
NPT2 | Others | Unspecified | Potency | 3378 | nM | 18227183 | ||
NPT2 | Others | Unspecified | Potency | 1693 | nM | 19029325 | ||
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 80000 | nM | 24927053 |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 6740 | nM | 10.1016/j.indcrop.2012.05.026 | |
NPT2 | Others | Unspecified | Inhibition | = | 94 | % | 15921411 | |
NPT2 | Others | Unspecified | AC50 | 39810.7 | nM | 22071302 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC96930 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC32017 |
0.9929 | High Similarity | NPC273358 |
0.9929 | High Similarity | NPC298647 |
0.9929 | High Similarity | NPC292206 |
0.9786 | High Similarity | NPC235195 |
0.9786 | High Similarity | NPC19862 |
0.9645 | High Similarity | NPC280717 |
0.9645 | High Similarity | NPC271607 |
0.9448 | High Similarity | NPC470619 |
0.9448 | High Similarity | NPC208785 |
0.9448 | High Similarity | NPC470618 |
0.9448 | High Similarity | NPC145527 |
0.9388 | High Similarity | NPC205392 |
0.9388 | High Similarity | NPC105942 |
0.9371 | High Similarity | NPC307205 |
0.9231 | High Similarity | NPC252133 |
0.9225 | High Similarity | NPC473612 |
0.922 | High Similarity | NPC132723 |
0.922 | High Similarity | NPC76032 |
0.9161 | High Similarity | NPC35212 |
0.9097 | High Similarity | NPC310621 |
0.9034 | High Similarity | NPC26045 |
0.8993 | High Similarity | NPC118033 |
0.8966 | High Similarity | NPC235557 |
0.8933 | High Similarity | NPC475579 |
0.8933 | High Similarity | NPC473773 |
0.8912 | High Similarity | NPC8102 |
0.8912 | High Similarity | NPC66894 |
0.8867 | High Similarity | NPC475311 |
0.8867 | High Similarity | NPC473579 |
0.8867 | High Similarity | NPC473680 |
0.8867 | High Similarity | NPC475454 |
0.8819 | High Similarity | NPC182249 |
0.8759 | High Similarity | NPC473591 |
0.8759 | High Similarity | NPC271494 |
0.8759 | High Similarity | NPC470616 |
0.8759 | High Similarity | NPC106055 |
0.8759 | High Similarity | NPC470617 |
0.8759 | High Similarity | NPC110699 |
0.8759 | High Similarity | NPC155192 |
0.8734 | High Similarity | NPC200726 |
0.8714 | High Similarity | NPC30174 |
0.869 | High Similarity | NPC116742 |
0.869 | High Similarity | NPC139243 |
0.8681 | High Similarity | NPC476699 |
0.8679 | High Similarity | NPC177362 |
0.8679 | High Similarity | NPC286809 |
0.8671 | High Similarity | NPC11266 |
0.8625 | High Similarity | NPC202428 |
0.8625 | High Similarity | NPC266545 |
0.8581 | High Similarity | NPC469447 |
0.8581 | High Similarity | NPC477873 |
0.8552 | High Similarity | NPC120852 |
0.8523 | High Similarity | NPC471876 |
0.8506 | High Similarity | NPC115203 |
0.8467 | Intermediate Similarity | NPC53520 |
0.8451 | Intermediate Similarity | NPC83062 |
0.8435 | Intermediate Similarity | NPC234548 |
0.8435 | Intermediate Similarity | NPC248287 |
0.8403 | Intermediate Similarity | NPC321502 |
0.8389 | Intermediate Similarity | NPC67467 |
0.8369 | Intermediate Similarity | NPC213552 |
0.8369 | Intermediate Similarity | NPC120225 |
0.8367 | Intermediate Similarity | NPC471152 |
0.8357 | Intermediate Similarity | NPC60517 |
0.8357 | Intermediate Similarity | NPC146886 |
0.8357 | Intermediate Similarity | NPC20443 |
0.8322 | Intermediate Similarity | NPC304110 |
0.8322 | Intermediate Similarity | NPC86257 |
0.8322 | Intermediate Similarity | NPC29599 |
0.8322 | Intermediate Similarity | NPC27518 |
0.8301 | Intermediate Similarity | NPC102934 |
0.8301 | Intermediate Similarity | NPC252402 |
0.8298 | Intermediate Similarity | NPC289459 |
0.8291 | Intermediate Similarity | NPC125495 |
0.8255 | Intermediate Similarity | NPC471875 |
0.8252 | Intermediate Similarity | NPC478215 |
0.8231 | Intermediate Similarity | NPC252343 |
0.8227 | Intermediate Similarity | NPC10154 |
0.8227 | Intermediate Similarity | NPC246704 |
0.8227 | Intermediate Similarity | NPC265413 |
0.8224 | Intermediate Similarity | NPC163898 |
0.8224 | Intermediate Similarity | NPC473909 |
0.8224 | Intermediate Similarity | NPC274960 |
0.8224 | Intermediate Similarity | NPC143120 |
0.8205 | Intermediate Similarity | NPC478268 |
0.8194 | Intermediate Similarity | NPC288290 |
0.8176 | Intermediate Similarity | NPC90431 |
0.8169 | Intermediate Similarity | NPC266705 |
0.8169 | Intermediate Similarity | NPC228771 |
0.8169 | Intermediate Similarity | NPC29008 |
0.8163 | Intermediate Similarity | NPC471942 |
0.8163 | Intermediate Similarity | NPC67247 |
0.8158 | Intermediate Similarity | NPC25491 |
0.8158 | Intermediate Similarity | NPC96447 |
0.8153 | Intermediate Similarity | NPC475141 |
0.8146 | Intermediate Similarity | NPC472410 |
0.8143 | Intermediate Similarity | NPC70752 |
0.8141 | Intermediate Similarity | NPC178048 |
0.8133 | Intermediate Similarity | NPC475197 |
0.8133 | Intermediate Similarity | NPC473467 |
0.8125 | Intermediate Similarity | NPC201069 |
0.8125 | Intermediate Similarity | NPC277458 |
0.8125 | Intermediate Similarity | NPC478269 |
0.8125 | Intermediate Similarity | NPC307050 |
0.8121 | Intermediate Similarity | NPC281780 |
0.8121 | Intermediate Similarity | NPC472803 |
0.8108 | Intermediate Similarity | NPC477874 |
0.8108 | Intermediate Similarity | NPC173569 |
0.8101 | Intermediate Similarity | NPC473736 |
0.8101 | Intermediate Similarity | NPC62051 |
0.8095 | Intermediate Similarity | NPC227719 |
0.8095 | Intermediate Similarity | NPC475468 |
0.8089 | Intermediate Similarity | NPC124842 |
0.8077 | Intermediate Similarity | NPC261322 |
0.8072 | Intermediate Similarity | NPC469772 |
0.8072 | Intermediate Similarity | NPC469778 |
0.8072 | Intermediate Similarity | NPC469777 |
0.8072 | Intermediate Similarity | NPC469774 |
0.8072 | Intermediate Similarity | NPC32723 |
0.8072 | Intermediate Similarity | NPC100925 |
0.8072 | Intermediate Similarity | NPC469775 |
0.8072 | Intermediate Similarity | NPC135334 |
0.8072 | Intermediate Similarity | NPC295941 |
0.8072 | Intermediate Similarity | NPC469773 |
0.8072 | Intermediate Similarity | NPC469776 |
0.8071 | Intermediate Similarity | NPC204466 |
0.8067 | Intermediate Similarity | NPC318575 |
0.8065 | Intermediate Similarity | NPC236166 |
0.8065 | Intermediate Similarity | NPC95990 |
0.8054 | Intermediate Similarity | NPC471988 |
0.8054 | Intermediate Similarity | NPC68292 |
0.8054 | Intermediate Similarity | NPC249817 |
0.8042 | Intermediate Similarity | NPC9067 |
0.8041 | Intermediate Similarity | NPC4982 |
0.8041 | Intermediate Similarity | NPC135127 |
0.8041 | Intermediate Similarity | NPC300776 |
0.8041 | Intermediate Similarity | NPC471110 |
0.8041 | Intermediate Similarity | NPC5310 |
0.8041 | Intermediate Similarity | NPC68779 |
0.8041 | Intermediate Similarity | NPC176814 |
0.8039 | Intermediate Similarity | NPC238216 |
0.8039 | Intermediate Similarity | NPC208994 |
0.8039 | Intermediate Similarity | NPC224884 |
0.8039 | Intermediate Similarity | NPC185388 |
0.8039 | Intermediate Similarity | NPC209085 |
0.8039 | Intermediate Similarity | NPC84684 |
0.8037 | Intermediate Similarity | NPC100420 |
0.8028 | Intermediate Similarity | NPC31344 |
0.8028 | Intermediate Similarity | NPC317769 |
0.8027 | Intermediate Similarity | NPC227002 |
0.8026 | Intermediate Similarity | NPC131971 |
0.8025 | Intermediate Similarity | NPC478267 |
0.8025 | Intermediate Similarity | NPC216916 |
0.8025 | Intermediate Similarity | NPC261659 |
0.8013 | Intermediate Similarity | NPC279442 |
0.8013 | Intermediate Similarity | NPC475250 |
0.8013 | Intermediate Similarity | NPC253591 |
0.8 | Intermediate Similarity | NPC198621 |
0.8 | Intermediate Similarity | NPC472938 |
0.8 | Intermediate Similarity | NPC472937 |
0.8 | Intermediate Similarity | NPC475482 |
0.8 | Intermediate Similarity | NPC202474 |
0.8 | Intermediate Similarity | NPC126206 |
0.8 | Intermediate Similarity | NPC11411 |
0.8 | Intermediate Similarity | NPC208818 |
0.8 | Intermediate Similarity | NPC478248 |
0.8 | Intermediate Similarity | NPC472936 |
0.8 | Intermediate Similarity | NPC22676 |
0.8 | Intermediate Similarity | NPC216940 |
0.8 | Intermediate Similarity | NPC110313 |
0.7987 | Intermediate Similarity | NPC43353 |
0.7974 | Intermediate Similarity | NPC470273 |
0.7963 | Intermediate Similarity | NPC478265 |
0.7961 | Intermediate Similarity | NPC470372 |
0.7961 | Intermediate Similarity | NPC78987 |
0.7961 | Intermediate Similarity | NPC82336 |
0.795 | Intermediate Similarity | NPC471878 |
0.795 | Intermediate Similarity | NPC470827 |
0.7943 | Intermediate Similarity | NPC470848 |
0.7943 | Intermediate Similarity | NPC470849 |
0.7933 | Intermediate Similarity | NPC154485 |
0.7933 | Intermediate Similarity | NPC471664 |
0.7933 | Intermediate Similarity | NPC471665 |
0.7933 | Intermediate Similarity | NPC470733 |
0.7933 | Intermediate Similarity | NPC471872 |
0.7927 | Intermediate Similarity | NPC45943 |
0.7925 | Intermediate Similarity | NPC223720 |
0.7922 | Intermediate Similarity | NPC264706 |
0.7922 | Intermediate Similarity | NPC284881 |
0.7922 | Intermediate Similarity | NPC93433 |
0.7922 | Intermediate Similarity | NPC474444 |
0.7922 | Intermediate Similarity | NPC471065 |
0.7922 | Intermediate Similarity | NPC253015 |
0.7919 | Intermediate Similarity | NPC141023 |
0.7919 | Intermediate Similarity | NPC311256 |
0.7919 | Intermediate Similarity | NPC473054 |
0.7914 | Intermediate Similarity | NPC149873 |
0.7914 | Intermediate Similarity | NPC7191 |
0.7911 | Intermediate Similarity | NPC269914 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC96930 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8481 | Intermediate Similarity | NPD8127 | Discontinued |
0.8403 | Intermediate Similarity | NPD3619 | Clinical (unspecified phase) |
0.8403 | Intermediate Similarity | NPD3620 | Phase 2 |
0.8389 | Intermediate Similarity | NPD8166 | Discontinued |
0.8027 | Intermediate Similarity | NPD4140 | Approved |
0.7885 | Intermediate Similarity | NPD6273 | Approved |
0.7829 | Intermediate Similarity | NPD5762 | Approved |
0.7829 | Intermediate Similarity | NPD5763 | Approved |
0.7808 | Intermediate Similarity | NPD5736 | Approved |
0.7792 | Intermediate Similarity | NPD4109 | Clinical (unspecified phase) |
0.7792 | Intermediate Similarity | NPD4110 | Phase 3 |
0.7785 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7733 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7733 | Intermediate Similarity | NPD5735 | Approved |
0.7688 | Intermediate Similarity | NPD7028 | Phase 2 |
0.7655 | Intermediate Similarity | NPD5327 | Phase 3 |
0.7655 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7622 | Intermediate Similarity | NPD7832 | Clinical (unspecified phase) |
0.7622 | Intermediate Similarity | NPD7833 | Phase 2 |
0.7622 | Intermediate Similarity | NPD7831 | Phase 2 |
0.7616 | Intermediate Similarity | NPD3657 | Discovery |
0.76 | Intermediate Similarity | NPD8032 | Phase 2 |
0.76 | Intermediate Similarity | NPD6663 | Approved |
0.7584 | Intermediate Similarity | NPD7095 | Approved |
0.7576 | Intermediate Similarity | NPD6234 | Discontinued |
0.7566 | Intermediate Similarity | NPD6353 | Approved |
0.7516 | Intermediate Similarity | NPD7458 | Discontinued |
0.75 | Intermediate Similarity | NPD7685 | Pre-registration |
0.75 | Intermediate Similarity | NPD4626 | Approved |
0.75 | Intermediate Similarity | NPD4624 | Approved |
0.75 | Intermediate Similarity | NPD6355 | Discontinued |
0.7484 | Intermediate Similarity | NPD7266 | Discontinued |
0.7471 | Intermediate Similarity | NPD7228 | Approved |
0.7452 | Intermediate Similarity | NPD7003 | Approved |
0.7431 | Intermediate Similarity | NPD5691 | Approved |
0.7403 | Intermediate Similarity | NPD7097 | Phase 1 |
0.7401 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7397 | Intermediate Similarity | NPD3092 | Approved |
0.7389 | Intermediate Similarity | NPD6674 | Discontinued |
0.7378 | Intermediate Similarity | NPD37 | Approved |
0.7376 | Intermediate Similarity | NPD5283 | Phase 1 |
0.7375 | Intermediate Similarity | NPD7446 | Clinical (unspecified phase) |
0.7361 | Intermediate Similarity | NPD3091 | Approved |
0.7357 | Intermediate Similarity | NPD228 | Approved |
0.7351 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7349 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7349 | Intermediate Similarity | NPD4965 | Approved |
0.7349 | Intermediate Similarity | NPD4966 | Approved |
0.7342 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7315 | Intermediate Similarity | NPD3094 | Phase 2 |
0.7312 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7278 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7246 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7226 | Intermediate Similarity | NPD6653 | Approved |
0.7225 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7219 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7193 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7192 | Intermediate Similarity | NPD1357 | Approved |
0.719 | Intermediate Similarity | NPD6798 | Discontinued |
0.7172 | Intermediate Similarity | NPD5536 | Phase 2 |
0.716 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7153 | Intermediate Similarity | NPD7157 | Approved |
0.7151 | Intermediate Similarity | NPD2898 | Approved |
0.7143 | Intermediate Similarity | NPD3095 | Discontinued |
0.7143 | Intermediate Similarity | NPD3019 | Approved |
0.7134 | Intermediate Similarity | NPD1653 | Approved |
0.7125 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.711 | Intermediate Similarity | NPD7473 | Discontinued |
0.7097 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7097 | Intermediate Similarity | NPD1613 | Approved |
0.7095 | Intermediate Similarity | NPD3496 | Discontinued |
0.7092 | Intermediate Similarity | NPD3021 | Approved |
0.7092 | Intermediate Similarity | NPD3022 | Approved |
0.7091 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7075 | Intermediate Similarity | NPD5585 | Approved |
0.7071 | Intermediate Similarity | NPD1358 | Approved |
0.7067 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.7055 | Intermediate Similarity | NPD4160 | Clinical (unspecified phase) |
0.7052 | Intermediate Similarity | NPD2489 | Approved |
0.7052 | Intermediate Similarity | NPD27 | Approved |
0.7035 | Intermediate Similarity | NPD6232 | Discontinued |
0.7027 | Intermediate Similarity | NPD2932 | Approved |
0.7027 | Intermediate Similarity | NPD4059 | Approved |
0.7022 | Intermediate Similarity | NPD7311 | Approved |
0.7022 | Intermediate Similarity | NPD7310 | Approved |
0.7022 | Intermediate Similarity | NPD7313 | Approved |
0.7022 | Intermediate Similarity | NPD7312 | Approved |
0.702 | Intermediate Similarity | NPD1283 | Approved |
0.702 | Intermediate Similarity | NPD8651 | Approved |
0.7019 | Intermediate Similarity | NPD6331 | Phase 2 |
0.7012 | Intermediate Similarity | NPD7314 | Clinical (unspecified phase) |
0.7006 | Intermediate Similarity | NPD4097 | Suspended |
0.7006 | Intermediate Similarity | NPD7240 | Approved |
0.7 | Intermediate Similarity | NPD3134 | Approved |
0.6993 | Remote Similarity | NPD9494 | Approved |
0.6983 | Remote Similarity | NPD7309 | Approved |
0.6981 | Remote Similarity | NPD2438 | Suspended |
0.6981 | Remote Similarity | NPD2935 | Discontinued |
0.6975 | Remote Similarity | NPD6190 | Approved |
0.697 | Remote Similarity | NPD5699 | Approved |
0.6968 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6964 | Remote Similarity | NPD1934 | Approved |
0.6954 | Remote Similarity | NPD4481 | Phase 3 |
0.6949 | Remote Similarity | NPD7993 | Clinical (unspecified phase) |
0.6948 | Remote Similarity | NPD4908 | Phase 1 |
0.6948 | Remote Similarity | NPD1529 | Clinical (unspecified phase) |
0.6944 | Remote Similarity | NPD7843 | Approved |
0.6944 | Remote Similarity | NPD5535 | Approved |
0.6941 | Remote Similarity | NPD7768 | Phase 2 |
0.6936 | Remote Similarity | NPD3051 | Approved |
0.6933 | Remote Similarity | NPD7236 | Approved |
0.6933 | Remote Similarity | NPD3705 | Approved |
0.6927 | Remote Similarity | NPD8312 | Approved |
0.6927 | Remote Similarity | NPD4578 | Approved |
0.6927 | Remote Similarity | NPD3534 | Clinical (unspecified phase) |
0.6927 | Remote Similarity | NPD8313 | Approved |
0.6927 | Remote Similarity | NPD4577 | Approved |
0.6923 | Remote Similarity | NPD2393 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD6233 | Phase 2 |
0.6918 | Remote Similarity | NPD4198 | Discontinued |
0.6905 | Remote Similarity | NPD6873 | Phase 2 |
0.6905 | Remote Similarity | NPD6677 | Suspended |
0.6899 | Remote Similarity | NPD4579 | Clinical (unspecified phase) |
0.6897 | Remote Similarity | NPD2970 | Approved |
0.6897 | Remote Similarity | NPD2969 | Approved |
0.6894 | Remote Similarity | NPD7037 | Approved |
0.6892 | Remote Similarity | NPD7741 | Discontinued |
0.6889 | Remote Similarity | NPD7090 | Clinical (unspecified phase) |
0.6883 | Remote Similarity | NPD1530 | Clinical (unspecified phase) |
0.6879 | Remote Similarity | NPD2979 | Phase 3 |
0.6868 | Remote Similarity | NPD7906 | Approved |
0.6864 | Remote Similarity | NPD7945 | Clinical (unspecified phase) |
0.6863 | Remote Similarity | NPD2797 | Approved |
0.6859 | Remote Similarity | NPD6410 | Clinical (unspecified phase) |
0.6857 | Remote Similarity | NPD6168 | Clinical (unspecified phase) |
0.6857 | Remote Similarity | NPD6166 | Phase 2 |
0.6857 | Remote Similarity | NPD6167 | Clinical (unspecified phase) |
0.6852 | Remote Similarity | NPD7421 | Clinical (unspecified phase) |
0.6842 | Remote Similarity | NPD7497 | Discontinued |
0.6842 | Remote Similarity | NPD4359 | Approved |
0.6842 | Remote Similarity | NPD3882 | Suspended |
0.6835 | Remote Similarity | NPD5124 | Phase 1 |
0.6835 | Remote Similarity | NPD5123 | Clinical (unspecified phase) |
0.6824 | Remote Similarity | NPD8455 | Phase 2 |
0.6824 | Remote Similarity | NPD1465 | Phase 2 |
0.6824 | Remote Similarity | NPD7819 | Suspended |
0.6821 | Remote Similarity | NPD1281 | Approved |
0.6818 | Remote Similarity | NPD5647 | Approved |
0.6818 | Remote Similarity | NPD6917 | Clinical (unspecified phase) |
0.6813 | Remote Similarity | NPD8434 | Phase 2 |
0.6813 | Remote Similarity | NPD2799 | Discontinued |
0.681 | Remote Similarity | NPD7982 | Clinical (unspecified phase) |
0.6802 | Remote Similarity | NPD7075 | Discontinued |
0.68 | Remote Similarity | NPD1778 | Approved |
0.6798 | Remote Similarity | NPD7074 | Phase 3 |
0.6797 | Remote Similarity | NPD1876 | Approved |
0.6795 | Remote Similarity | NPD5952 | Clinical (unspecified phase) |
0.6793 | Remote Similarity | NPD2490 | Approved |
0.6793 | Remote Similarity | NPD2488 | Approved |
0.679 | Remote Similarity | NPD5958 | Discontinued |
0.679 | Remote Similarity | NPD4534 | Discontinued |
0.6788 | Remote Similarity | NPD7040 | Clinical (unspecified phase) |
0.6788 | Remote Similarity | NPD7041 | Phase 2 |
0.6786 | Remote Similarity | NPD3455 | Phase 2 |
0.6783 | Remote Similarity | NPD2684 | Approved |
0.678 | Remote Similarity | NPD3818 | Discontinued |
0.6778 | Remote Similarity | NPD7549 | Discontinued |
0.677 | Remote Similarity | NPD2161 | Phase 2 |
0.6766 | Remote Similarity | NPD6980 | Clinical (unspecified phase) |
0.6765 | Remote Similarity | NPD5714 | Approved |
0.6765 | Remote Similarity | NPD5722 | Discontinued |
0.6757 | Remote Similarity | NPD7879 | Clinical (unspecified phase) |
0.6755 | Remote Similarity | NPD3026 | Approved |
0.6755 | Remote Similarity | NPD3023 | Approved |
0.6754 | Remote Similarity | NPD7680 | Approved |
0.6753 | Remote Similarity | NPD987 | Approved |
0.6752 | Remote Similarity | NPD3764 | Approved |
0.6752 | Remote Similarity | NPD7985 | Registered |
0.6752 | Remote Similarity | NPD3268 | Approved |
0.6748 | Remote Similarity | NPD5698 | Clinical (unspecified phase) |
0.6747 | Remote Similarity | NPD7422 | Clinical (unspecified phase) |
0.6742 | Remote Similarity | NPD7054 | Approved |
0.6733 | Remote Similarity | NPD3025 | Approved |
0.6733 | Remote Similarity | NPD3024 | Approved |
0.673 | Remote Similarity | NPD447 | Suspended |
0.673 | Remote Similarity | NPD4340 | Discontinued |
0.6728 | Remote Similarity | NPD2346 | Discontinued |
0.6726 | Remote Similarity | NPD7239 | Suspended |
0.6725 | Remote Similarity | NPD2801 | Approved |
0.6725 | Remote Similarity | NPD7096 | Clinical (unspecified phase) |
0.6724 | Remote Similarity | NPD4666 | Phase 3 |
0.6724 | Remote Similarity | NPD5494 | Approved |
0.6721 | Remote Similarity | NPD4663 | Approved |
0.672 | Remote Similarity | NPD7237 | Clinical (unspecified phase) |
0.6711 | Remote Similarity | NPD1611 | Approved |
0.671 | Remote Similarity | NPD6584 | Phase 3 |
0.6709 | Remote Similarity | NPD4870 | Approved |
0.6709 | Remote Similarity | NPD4062 | Phase 3 |
0.6709 | Remote Similarity | NPD1726 | Clinical (unspecified phase) |
0.6708 | Remote Similarity | NPD7743 | Approved |
PubChem CID   | 5282164 |
ChEMBL   | CHEMBL388595 |
ZINC   |
Molecular Weight:   | 602.43 |
ALogP:   | 3.5158 |
MLogP:   | 5.42 |
XLogP:   | 13.972 |
# Rotatable Bonds:   | 18 |
Polar Surface Area:   | 55.76 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 1 |
# Rings:   | 6 |
# Heavy Atoms:   | 44 |